TTXTETRATHERIX LIMITED

Announcement history available from 1 August 2025

Fromto
Date / TimeTitleTypeMSReport Codes
20 Aug 2026, 23:07Results Presentation 2026Financial Results03003, 03026
20 Aug 2026, 19:05Appendix 4E and Annual Report 2026Financial ResultsMS03001, 03002, 03003, 03011, 03012, 03013, 03020
22 July 2026, 18:24Quarterly Activities/Appendix 4C Cash Flow ReportQuarterly ReportsMS19004, 19009
1 July 2026, 23:53Notification regarding unquoted securities - TTXOther06021
23 June 2026, 19:53Tutela Interim Study ResultsCompany Update11001
23 June 2026, 18:15Application for quotation of securities - TTXOther06020
22 June 2026, 18:17SPP ResultsCapital Raising06017
19 June 2026, 18:19Application for quotation of securities - TTXOther06020
9 June 2026, 20:46Mandatory Escrow ReleaseSecurities Administration06009
9 June 2026, 18:33Study Results Peptide-Polymer PatentsCompany Update11001
4 June 2026, 19:16SPP BookletCapital Raising06017
4 June 2026, 19:10Placement Cleansing NoticeSecurities Administration06018
3 June 2026, 18:20Application for quotation of securities - TTXOther06020
28 May 2026, 19:23Proposed issue of securities - TTXSecurities Administration06013
28 May 2026, 19:22Successful Completion $15M PlacementCapital RaisingMS03026, 06003, 06017, 09014
26 May 2026, 19:29Trading HaltTrading Halt / SuspensionMS09007
23 Apr 2026, 19:26Quarterly Activities/Appendix 4C Cash Flow ReportQuarterly ReportsMS19003, 19008
1 Apr 2026, 19:20Notification regarding unquoted securities - TTXOther06021
17 Mar 2026, 19:30Tetratherix March Investor PresentationPresentations03026
16 Mar 2026, 19:17Precision medicine franchise launch and new revenueCompany UpdateMS11001
10 Mar 2026, 20:21Tutelix UpdateCompany UpdateMS11001
24 Feb 2026, 22:08HY FY26 LetterFinancial Results03004, 03014
24 Feb 2026, 21:27Half Yearly Report and AccountsFinancial ResultsMS03004, 03009, 03010, 03015, 03019
17 Feb 2026, 19:15TetraDerm Cohort 1 ResultsCompany UpdateMS11001
28 Jan 2026, 19:21Quarterly Activities/Appendix 4C Cash Flow ReportQuarterly ReportsMS19002, 19007
21 Jan 2026, 22:51Initial Director's Interest NoticeDirector Interests02008
21 Jan 2026, 22:47Vecchione AppointmentCompany Administration12001
19 Jan 2026, 19:28Executed Henry Schein AgreementCompany UpdateMS11001
13 Jan 2026, 19:25TetraDerm Cohort 2Company UpdateMS11001
9 Jan 2026, 19:19Application for quotation of securities - TTXOther06020
6 Jan 2026, 07:00Notification regarding unquoted securities - TTXOther06021
22 Dec 2025, 20:04Initial Director's Interest NoticeDirector Interests02008
19 Dec 2025, 04:18Application for quotation of securities - TTXOther06020
18 Dec 2025, 22:42Final Director's Interest NoticeDirector Interests02010
16 Dec 2025, 19:21Director Company Secretary Appointment/ResignationCompany Administration12001, 12007
9 Dec 2025, 03:46Application for quotation of securities - TTXOther06020
1 Dec 2025, 19:29BioOptix Alcon UpdateCompany Update11001
20 Nov 2025, 22:48Notice of Escrow ReleaseSecurities Administration06009
11 Nov 2025, 02:12Results of Annual General MeetingMeetings & Governance08003
10 Nov 2025, 20:272025 AGM Chair and CEO AddressLetters & Addresses15002
27 Oct 2025, 19:31Q1FY26 Quarterly Activities Report/Appendix 4CQuarterly ReportsMS19001, 19006
14 Oct 2025, 19:42Tutela UpdateCompany Update11001
10 Oct 2025, 03:242025 Notice of Annual General MeetingMeetings & Governance08001, 08004
9 Sept 2025, 01:24Application for quotation of securities - TTXOther06020
5 Sept 2025, 23:43Application for quotation of securities - TTXOther06020
29 Aug 2025, 22:30Notice of Escrow ReleaseSecurities Administration06009
28 Aug 2025, 19:272025 Financial Results Investor WebinarCompany Administration12008
28 Aug 2025, 19:262025 Financial Results Investor PresentationFinancial ResultsMS03003, 03026
28 Aug 2025, 19:15Appendix 4G and Corporate Governance StatementCompany Administration03024, 03025
28 Aug 2025, 19:082025 Financial Results AnnouncementFinancial ResultsMS03003, 03014
1–50 of 53
1 / 2